Progress in cancer biology is hampered by the difficulty to grow them in a realistic environment. The best models currently available are 3D tumour organoids. They are typically grown in animal-derived basement membrane extracts, which suffer from lot-to-lot variability and have a heterogeneous and complex composition, which makes it virtually impossible to systematically map parameters that affect tumour growth or treatment efficacy. To increase our collective knowledge on cancer biology and therapies, improved matrices are urgently needed. This project uses a synthetic biomimetic extracellular matrix, based on synthetic polyisocyanides (PICs). It is animal-free, cost-effective and easy to use. The ultimate goal is to establish a novel organoid platform for in vitro cancer modelling, personalised medicine and biobanking of patient-derived organoids for drug screenings or toxicology assays. As a proof of concept in this KWF-funded project, we aim to establish a PIC-based head and neck squamous cell cancer (HNSCC) ORGAnoid maTRIX platform, called ORGATRIX.
This project is a close collaboration between
Dr Paul Kouwer's group at Radboud University and Dr Marleen Ansems' group at the Radboud university medical center. As a postdoctoral researcher working on this project, you will be expected to work in both labs, which are conveniently located across the street from each other.
In the Kouwer Lab, you will prepare and modify PIC gels using protocols optimised for scientists without a strong materials chemistry background. Organoid cultures will be grown in these different PIC gels in the Ansems Lab. The team will hold biweekly meetings to exchange information, monitor progress and prioritise tasks.
A technician will be available to provide support in the cell biology experiments.